Back to AMLX
Point72 Asset Management, L.P. → AMLX
Point72 Asset Management, L.P. AMLX Position History
Amylyx Pharmaceuticals, Inc. • Healthcare
Quarters held
13
Latest value
$136K
Q2 2026
Peak value
$40.5M
First seen
Q2 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2023 | $153K |
| Q3 2023 | $842 |
| Q4 2023 | $40.5M |
| Q1 2024 | $483K |
| Q3 2024 | $648 |
| Q1 2025 | $3.2M |
| Q1 2025 | $3.2M |
| Q2 2025 | $29.1M |
| Q3 2025 | $37.9M |
| Q4 2025 | $4M |
| Q1 2026 | $1.5M |
| Q2 2026 | $147K |
| Q2 2026 | $136K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $136K | 7.6K | — | — |
| Q2 2026 | $147K | 8.2K | — | — |
| Q1 2026 | $1.5M | 106.5K | — | — |
| Q4 2025 | $4M | 335.0K | — | — |
| Q3 2025 | $37.9M | 2.79M | — | — |
| Q2 2025 | $29.1M | 4.54M | — | — |
| Q1 2025 | $3.2M | 917.0K | — | — |
| Q1 2025 | $3.2M | 917.0K | — | — |
| Q3 2024 | $648 | 200 | — | — |
| Q1 2024 | $483K | 170.0K | — | — |
| Q4 2023 | $40.5M | 2.75M | — | — |
| Q3 2023 | $842 | 46 | — | — |
| Q2 2023 | $153K | 7.1K | — | — |